Top Banner
Optimal Management of ACS Invasive vs Conservative Strategy Layth Mimish Consultant Cardiologist The Cardiovascular Consultant Group Jeddah KSA
74

Optimal Management of ACS Invasive vs Conservative Strategy Layth Mimish Consultant Cardiologist The Cardiovascular Consultant Group Jeddah KSA.

Dec 19, 2015

Download

Documents

Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: Optimal Management of ACS Invasive vs Conservative Strategy Layth Mimish Consultant Cardiologist The Cardiovascular Consultant Group Jeddah KSA.

Optimal Management ofACS

Invasive vs Conservative StrategyLayth Mimish

Consultant Cardiologist

The Cardiovascular Consultant Group

Jeddah KSA

Page 2: Optimal Management of ACS Invasive vs Conservative Strategy Layth Mimish Consultant Cardiologist The Cardiovascular Consultant Group Jeddah KSA.
Page 3: Optimal Management of ACS Invasive vs Conservative Strategy Layth Mimish Consultant Cardiologist The Cardiovascular Consultant Group Jeddah KSA.
Page 4: Optimal Management of ACS Invasive vs Conservative Strategy Layth Mimish Consultant Cardiologist The Cardiovascular Consultant Group Jeddah KSA.
Page 5: Optimal Management of ACS Invasive vs Conservative Strategy Layth Mimish Consultant Cardiologist The Cardiovascular Consultant Group Jeddah KSA.
Page 6: Optimal Management of ACS Invasive vs Conservative Strategy Layth Mimish Consultant Cardiologist The Cardiovascular Consultant Group Jeddah KSA.

Approach To ACS

Risk stratification Appropriate acute medical management Identify coronary anatomy in higher risk

patients, otherwise exercise imaging PCI vs CABG based on extent of coronary

disease, LV function, and co morbid factors Long term medical management ; risk factors

modification

Page 7: Optimal Management of ACS Invasive vs Conservative Strategy Layth Mimish Consultant Cardiologist The Cardiovascular Consultant Group Jeddah KSA.

TIMI Risk Score for ACSUnfractionated Heparin Cohort TIMI 11B (n=1957)

Age > 65 years> 3 CAD risk factorsPrior CAD Stenosis > 50%ST segment changes on presentation> 2 anginal events in last 24 HrsASA use < 7years Increased serum cardiac markers

Page 8: Optimal Management of ACS Invasive vs Conservative Strategy Layth Mimish Consultant Cardiologist The Cardiovascular Consultant Group Jeddah KSA.
Page 9: Optimal Management of ACS Invasive vs Conservative Strategy Layth Mimish Consultant Cardiologist The Cardiovascular Consultant Group Jeddah KSA.
Page 10: Optimal Management of ACS Invasive vs Conservative Strategy Layth Mimish Consultant Cardiologist The Cardiovascular Consultant Group Jeddah KSA.

FRISC Score

Age>70 yearsDiabetes MellitusPrevious MIAngina > 30 daysST depressionElevated TroponinElevated FibrinogenElevated II-6 (2P)

Page 11: Optimal Management of ACS Invasive vs Conservative Strategy Layth Mimish Consultant Cardiologist The Cardiovascular Consultant Group Jeddah KSA.

2 Yr Mortality and MI

Mortality Death or MI

Page 12: Optimal Management of ACS Invasive vs Conservative Strategy Layth Mimish Consultant Cardiologist The Cardiovascular Consultant Group Jeddah KSA.
Page 13: Optimal Management of ACS Invasive vs Conservative Strategy Layth Mimish Consultant Cardiologist The Cardiovascular Consultant Group Jeddah KSA.
Page 14: Optimal Management of ACS Invasive vs Conservative Strategy Layth Mimish Consultant Cardiologist The Cardiovascular Consultant Group Jeddah KSA.
Page 15: Optimal Management of ACS Invasive vs Conservative Strategy Layth Mimish Consultant Cardiologist The Cardiovascular Consultant Group Jeddah KSA.

Culprit Lesion Morphology & Troponin Levels in UAP

Page 16: Optimal Management of ACS Invasive vs Conservative Strategy Layth Mimish Consultant Cardiologist The Cardiovascular Consultant Group Jeddah KSA.
Page 17: Optimal Management of ACS Invasive vs Conservative Strategy Layth Mimish Consultant Cardiologist The Cardiovascular Consultant Group Jeddah KSA.
Page 18: Optimal Management of ACS Invasive vs Conservative Strategy Layth Mimish Consultant Cardiologist The Cardiovascular Consultant Group Jeddah KSA.

Antithrombotic approaches in ACS

Acute Medical Management ASA & LMWH ( FRIC, FRISC I&II, ESSENCE, TIMI 11B) Direct Thrombin Inhibitors (GUSTO IIB, OASIS-2) GP IIb/IIIa Inhibitors (4P Trials, Oral trials, GUSTO-IV ACS,

TIMI-18) ASA & Clopidogril (CURE)

Coronary Interventions Direct Thrombin Inhibitors (HELVETICA, Hirulog Trials) GIIbIIa Inhibitors (EPIC, EPILOG, CAPTURE, EPISTENT,

IMPACT-2, RESTORE, ESPIRIT, TARGET) LMWH & GPIIb/IIIa Inhibitors(NICE Registry) ASA & Clopidogril (CREDO)

Page 19: Optimal Management of ACS Invasive vs Conservative Strategy Layth Mimish Consultant Cardiologist The Cardiovascular Consultant Group Jeddah KSA.
Page 20: Optimal Management of ACS Invasive vs Conservative Strategy Layth Mimish Consultant Cardiologist The Cardiovascular Consultant Group Jeddah KSA.
Page 21: Optimal Management of ACS Invasive vs Conservative Strategy Layth Mimish Consultant Cardiologist The Cardiovascular Consultant Group Jeddah KSA.
Page 22: Optimal Management of ACS Invasive vs Conservative Strategy Layth Mimish Consultant Cardiologist The Cardiovascular Consultant Group Jeddah KSA.
Page 23: Optimal Management of ACS Invasive vs Conservative Strategy Layth Mimish Consultant Cardiologist The Cardiovascular Consultant Group Jeddah KSA.
Page 24: Optimal Management of ACS Invasive vs Conservative Strategy Layth Mimish Consultant Cardiologist The Cardiovascular Consultant Group Jeddah KSA.
Page 25: Optimal Management of ACS Invasive vs Conservative Strategy Layth Mimish Consultant Cardiologist The Cardiovascular Consultant Group Jeddah KSA.
Page 26: Optimal Management of ACS Invasive vs Conservative Strategy Layth Mimish Consultant Cardiologist The Cardiovascular Consultant Group Jeddah KSA.
Page 27: Optimal Management of ACS Invasive vs Conservative Strategy Layth Mimish Consultant Cardiologist The Cardiovascular Consultant Group Jeddah KSA.
Page 28: Optimal Management of ACS Invasive vs Conservative Strategy Layth Mimish Consultant Cardiologist The Cardiovascular Consultant Group Jeddah KSA.
Page 29: Optimal Management of ACS Invasive vs Conservative Strategy Layth Mimish Consultant Cardiologist The Cardiovascular Consultant Group Jeddah KSA.
Page 30: Optimal Management of ACS Invasive vs Conservative Strategy Layth Mimish Consultant Cardiologist The Cardiovascular Consultant Group Jeddah KSA.
Page 31: Optimal Management of ACS Invasive vs Conservative Strategy Layth Mimish Consultant Cardiologist The Cardiovascular Consultant Group Jeddah KSA.
Page 32: Optimal Management of ACS Invasive vs Conservative Strategy Layth Mimish Consultant Cardiologist The Cardiovascular Consultant Group Jeddah KSA.
Page 33: Optimal Management of ACS Invasive vs Conservative Strategy Layth Mimish Consultant Cardiologist The Cardiovascular Consultant Group Jeddah KSA.

Overview of GP IIb/IIIa Trials by Pooled Analysis

Page 34: Optimal Management of ACS Invasive vs Conservative Strategy Layth Mimish Consultant Cardiologist The Cardiovascular Consultant Group Jeddah KSA.
Page 35: Optimal Management of ACS Invasive vs Conservative Strategy Layth Mimish Consultant Cardiologist The Cardiovascular Consultant Group Jeddah KSA.
Page 36: Optimal Management of ACS Invasive vs Conservative Strategy Layth Mimish Consultant Cardiologist The Cardiovascular Consultant Group Jeddah KSA.
Page 37: Optimal Management of ACS Invasive vs Conservative Strategy Layth Mimish Consultant Cardiologist The Cardiovascular Consultant Group Jeddah KSA.
Page 38: Optimal Management of ACS Invasive vs Conservative Strategy Layth Mimish Consultant Cardiologist The Cardiovascular Consultant Group Jeddah KSA.

Conservative X Invasive Trials in ACS

Page 39: Optimal Management of ACS Invasive vs Conservative Strategy Layth Mimish Consultant Cardiologist The Cardiovascular Consultant Group Jeddah KSA.

Conservative X Invasive Trials in ACS

Page 40: Optimal Management of ACS Invasive vs Conservative Strategy Layth Mimish Consultant Cardiologist The Cardiovascular Consultant Group Jeddah KSA.

TIMI - IIIB

Page 41: Optimal Management of ACS Invasive vs Conservative Strategy Layth Mimish Consultant Cardiologist The Cardiovascular Consultant Group Jeddah KSA.
Page 42: Optimal Management of ACS Invasive vs Conservative Strategy Layth Mimish Consultant Cardiologist The Cardiovascular Consultant Group Jeddah KSA.
Page 43: Optimal Management of ACS Invasive vs Conservative Strategy Layth Mimish Consultant Cardiologist The Cardiovascular Consultant Group Jeddah KSA.
Page 44: Optimal Management of ACS Invasive vs Conservative Strategy Layth Mimish Consultant Cardiologist The Cardiovascular Consultant Group Jeddah KSA.

Study Limitations of VANQUISH

High surgical mortality (7.7%) & 12% in invasive arm

PTCA performed prior to era of stents and GPIIb/Iia blockers

No PTCA for multivessel diseaseResults not necessarily applicable

to females

Page 45: Optimal Management of ACS Invasive vs Conservative Strategy Layth Mimish Consultant Cardiologist The Cardiovascular Consultant Group Jeddah KSA.
Page 46: Optimal Management of ACS Invasive vs Conservative Strategy Layth Mimish Consultant Cardiologist The Cardiovascular Consultant Group Jeddah KSA.
Page 47: Optimal Management of ACS Invasive vs Conservative Strategy Layth Mimish Consultant Cardiologist The Cardiovascular Consultant Group Jeddah KSA.
Page 48: Optimal Management of ACS Invasive vs Conservative Strategy Layth Mimish Consultant Cardiologist The Cardiovascular Consultant Group Jeddah KSA.
Page 49: Optimal Management of ACS Invasive vs Conservative Strategy Layth Mimish Consultant Cardiologist The Cardiovascular Consultant Group Jeddah KSA.
Page 50: Optimal Management of ACS Invasive vs Conservative Strategy Layth Mimish Consultant Cardiologist The Cardiovascular Consultant Group Jeddah KSA.
Page 51: Optimal Management of ACS Invasive vs Conservative Strategy Layth Mimish Consultant Cardiologist The Cardiovascular Consultant Group Jeddah KSA.
Page 52: Optimal Management of ACS Invasive vs Conservative Strategy Layth Mimish Consultant Cardiologist The Cardiovascular Consultant Group Jeddah KSA.
Page 53: Optimal Management of ACS Invasive vs Conservative Strategy Layth Mimish Consultant Cardiologist The Cardiovascular Consultant Group Jeddah KSA.
Page 54: Optimal Management of ACS Invasive vs Conservative Strategy Layth Mimish Consultant Cardiologist The Cardiovascular Consultant Group Jeddah KSA.
Page 55: Optimal Management of ACS Invasive vs Conservative Strategy Layth Mimish Consultant Cardiologist The Cardiovascular Consultant Group Jeddah KSA.
Page 56: Optimal Management of ACS Invasive vs Conservative Strategy Layth Mimish Consultant Cardiologist The Cardiovascular Consultant Group Jeddah KSA.
Page 57: Optimal Management of ACS Invasive vs Conservative Strategy Layth Mimish Consultant Cardiologist The Cardiovascular Consultant Group Jeddah KSA.
Page 58: Optimal Management of ACS Invasive vs Conservative Strategy Layth Mimish Consultant Cardiologist The Cardiovascular Consultant Group Jeddah KSA.
Page 59: Optimal Management of ACS Invasive vs Conservative Strategy Layth Mimish Consultant Cardiologist The Cardiovascular Consultant Group Jeddah KSA.

Conservative X Invasive Trials in ACS

Page 60: Optimal Management of ACS Invasive vs Conservative Strategy Layth Mimish Consultant Cardiologist The Cardiovascular Consultant Group Jeddah KSA.

Conservative X Invasive Trials in ACS

Page 61: Optimal Management of ACS Invasive vs Conservative Strategy Layth Mimish Consultant Cardiologist The Cardiovascular Consultant Group Jeddah KSA.

Conservative X Invasive Trials in ACS

Page 62: Optimal Management of ACS Invasive vs Conservative Strategy Layth Mimish Consultant Cardiologist The Cardiovascular Consultant Group Jeddah KSA.
Page 63: Optimal Management of ACS Invasive vs Conservative Strategy Layth Mimish Consultant Cardiologist The Cardiovascular Consultant Group Jeddah KSA.
Page 64: Optimal Management of ACS Invasive vs Conservative Strategy Layth Mimish Consultant Cardiologist The Cardiovascular Consultant Group Jeddah KSA.

MIDeath or MIMI Death or MI

Page 65: Optimal Management of ACS Invasive vs Conservative Strategy Layth Mimish Consultant Cardiologist The Cardiovascular Consultant Group Jeddah KSA.
Page 66: Optimal Management of ACS Invasive vs Conservative Strategy Layth Mimish Consultant Cardiologist The Cardiovascular Consultant Group Jeddah KSA.
Page 67: Optimal Management of ACS Invasive vs Conservative Strategy Layth Mimish Consultant Cardiologist The Cardiovascular Consultant Group Jeddah KSA.
Page 68: Optimal Management of ACS Invasive vs Conservative Strategy Layth Mimish Consultant Cardiologist The Cardiovascular Consultant Group Jeddah KSA.
Page 69: Optimal Management of ACS Invasive vs Conservative Strategy Layth Mimish Consultant Cardiologist The Cardiovascular Consultant Group Jeddah KSA.
Page 70: Optimal Management of ACS Invasive vs Conservative Strategy Layth Mimish Consultant Cardiologist The Cardiovascular Consultant Group Jeddah KSA.
Page 71: Optimal Management of ACS Invasive vs Conservative Strategy Layth Mimish Consultant Cardiologist The Cardiovascular Consultant Group Jeddah KSA.
Page 72: Optimal Management of ACS Invasive vs Conservative Strategy Layth Mimish Consultant Cardiologist The Cardiovascular Consultant Group Jeddah KSA.
Page 73: Optimal Management of ACS Invasive vs Conservative Strategy Layth Mimish Consultant Cardiologist The Cardiovascular Consultant Group Jeddah KSA.
Page 74: Optimal Management of ACS Invasive vs Conservative Strategy Layth Mimish Consultant Cardiologist The Cardiovascular Consultant Group Jeddah KSA.